The genes that regulate iron metabolisms, such as NFS1 (NFS1 cysteine desulfurase) (Alvarez et al., 2017) and CISD1 (CDGSH iron–sulfur domain 1) (Yuan et al., 2016), may become novel targets for tumor-targeted therapy. The gene discussed is CISD1; the disease is neoplasm.